Ceapro Inc.
CRPOF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.74 | 16.17 | 7.31 | -4.82 |
| FCF Yield | -0.64% | 0.29% | 0.14% | 0.16% |
| EV / EBITDA | -187.42 | 283.99 | 421.82 | 580.94 |
| Quality | ||||
| ROIC | -16.57% | 11.24% | 8.79% | 7.51% |
| Gross Margin | 36.99% | 58.48% | 56.35% | 50.41% |
| Cash Conversion Ratio | 0.77 | 1.51 | 1.24 | 2.40 |
| Growth | ||||
| Revenue 3-Year CAGR | -17.56% | 7.60% | 10.11% | 9.26% |
| Free Cash Flow Growth | -173.13% | 124.72% | -26.93% | 423.97% |
| Safety | ||||
| Net Debt / EBITDA | 1.72 | -1.48 | -1.09 | -0.59 |
| Interest Coverage | -48.82 | 40.89 | 15.91 | 12.08 |
| Efficiency | ||||
| Inventory Turnover | 1.14 | 2.08 | 4.56 | 6.20 |
| Cash Conversion Cycle | 253.09 | 150.47 | 92.22 | 58.15 |